For the Inventor, By the Inventor

Enter assignee name

Salt Lake City, UT, United States of America

Myriad Genetics, Inc.

USPTO Granted Patents = 116

CIPO Patents = 2

EPO Patents = 19

Trademarks = 35

Forward Citations = 1,094

Loading Chart...

Loading Chart...

139 inventors (with patents filed for the assignee):

Alexander Gutin (23 out of 28 patents)

Alexander Kamb (22 out of 25 patents)

Sean V Tavtigian (16 out of 26 patents)

4. Kirsten Timms (15 out of 15 patents)

5. Victor Abkevich (13 out of 15 patents)

6. Julia Reid (12 out of 13 patents)

7. Steven Stone (11 out of 12 patents)

8. Jerry Lanchbury (10 out of 11 patents)

9. Susanne Wagner (8 out of 8 patents)

10. Hwa-Ok Kim (7 out of 17 patents)

11. Donna Shattuck (7 out of 9 patents)

12. Thomas M Scholl (7 out of 7 patents)

13. Masakatsu Eguchi (6 out of 28 patents)

14. Deanna L Russell (6 out of 8 patents)

15. Mark H Skolnick (6 out of 9 patents)

Core Competencies:

Homologous Recombination Deficiency

Hereditary Cancer Genes

Biomarkers

Cancer Prognosis

Gene Signatures

Copy Number Variants

Loss of Heterozygosity

Melanoma Treatment

Depression-Related Genes

RNA Interference

Diabetes Genes

Obesity Genes

116 patents: Sort by Forward Citations

1. 12421555 - Methods and materials for assessing homologous recombination deficiency (2025-09-23),

2. 12410478 - Hereditary cancer genes (2025-09-09),

3. 12221656 - Methods and materials for assessing homologous recombination deficiency (2025-02-11),

4. 11505832 - Method of using biomarkers and clinical variables for predicting chemotherapy benefit (2022-11-22),

5. 11232850 - Copy number variant caller (2022-01-25),

6. 11225685 - Methods and materials for assessing allelic imbalance (2022-01-18),

7. 11174519 - Method of treating cancer (2021-11-16),

8. 11174517 - Gene signatures for cancer prognosis (2021-11-16),

9. 11104956 - Hereditary cancer genes (2021-08-31),

10. 11021752 - Genes and gene signatures for diagnosis and treatment of melanoma (2021-06-01),

11. 10954568 - Gene signatures for cancer prognosis (2021-03-23),

12. 10876164 - Gene signatures for cancer prognosis (2020-12-29),

13. 10851425 - Method for treating cancer (2020-12-01),

14. 10626449 - Methods and materials for assessing allelic imbalance (2020-04-21),

15. 10612099 - Genes and gene signatures for diagnosis and treatment of melanoma (2020-04-07),

Myriad Genetics, Inc. is a leading molecular diagnostic company that focuses on genetic testing and providing personalized medicine. They develop and market innovative products to assess an individual's risk for developing diseases, such as cancer, and to tailor treatments based on specific genetic characteristics. Myriad Genetics aims to improve the quality of patients' lives by offering advanced genetic testing solutions and empowering healthcare professionals with critical information to make informed treatment decisions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

116 Patents

#7 in Salt Lake City, UT

#27 in Utah

#3,189 in US

#6,645 in the World

Salt Lake City, UT, United States of America

Myriad Genetics, Inc.

Forward Citations = 1,094

139 inventors:

Alexander Gutin (23 out of 28 patents)

Alexander Kamb (22 out of 25 patents)

Sean V Tavtigian (16 out of 26 patents)

4. Kirsten Timms (15 out of 15 patents)

5. Victor Abkevich (13 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…